Showing results (61-70 of 236) with videos related to
Sort By:
Pageof 24
Frontiers in Cellular and Infection Microbiology|February 10, 2017
Oral Multiple Sclerosis Drugs Inhibit the <i>In vitro</i> Growth of Epsilon Toxin Producing Gut Bacterium, <i>Clostridium perfringens</i>Kareem R Rumah, Timothy K Vartanian, Vincent A FischettiInternational Journal of Food Microbiology|January 26, 2021
Decontamination of Escherichia coli O157:H7 on fresh Romaine lettuce using a novel bacteriophage lysinSiyue Xu, Edmondo Campisi, Jinquan Li, et al.Frontiers in Microbiology|April 4, 2022
PaP1, a Broad-Spectrum Lysin-Derived Cationic Peptide to Treat Polymicrobial Skin InfectionsRyan D Heselpoth, Chad W Euler, Vincent A FischettiAntimicrobial Agents and Chemotherapy|November 12, 2025
Second-generation lysocins as therapeutics for treating <i>Pseudomonas aeruginosa</i> infectionsRyan D Heselpoth, Chad W Euler, Vincent A FischettiDiagnostic Microbiology and Infectious Disease|August 31, 2019
In vitro activity of Exebacase (CF-301) against clinical Staphylococcus aureus surveillance isolates from the United States, Europe, and Latin America, 2015-2017Maria Traczewski, Jun Oh, Cara Cassino, et al.Antimicrobial Agents and Chemotherapy|September 23, 2015
Using a Novel Lysin To Help Control Clostridium difficile InfectionsQiong Wang, Chad W Euler, Aurelia Delaune, et al.Plos One|October 23, 2013
Isolation of Clostridium perfringens type B in an individual at first clinical presentation of multiple sclerosis provides clues for environmental triggers of the diseaseKareem Rashid Rumah, Jennifer Linden, Vincent A Fischetti, et al.Antimicrobial Agents and Chemotherapy|November 13, 2019
Exebacase Demonstrates <i>In Vitro</i> Synergy with a Broad Range of Antibiotics against both Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureusAubrey Watson, Karen Sauve, Cara Cassino, et al.Journal of Clinical Microbiology|April 29, 2021
Determination of MIC Quality Control Parameters for Exebacase, a Novel Lysin with Antistaphylococcal ActivityMaria M Traczewski, Jane E Ambler, Raymond SchuchAntimicrobial Agents and Chemotherapy|July 6, 2021
Exebacase Is Active <i>In Vitro</i> in Pulmonary Surfactant and Is Efficacious Alone and Synergistic with Daptomycin in a Mouse Model of Lethal Staphylococcus aureus Lung InfectionSteven M Swift, Karen Sauve, Cara Cassino, et al.Pageof 24